Mon, December 12, 2022
Fri, December 9, 2022
Thu, December 8, 2022
Wed, December 7, 2022
Tue, December 6, 2022
Mon, December 5, 2022
Sun, December 4, 2022
Fri, December 2, 2022

Judah Frommer Maintained (CADL) at Buy with Decreased Target to $8 on, Dec 7th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -with-decreased-target-to-8-on-dec-7th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Judah Frommer of Credit Suisse, Maintained "Candel Therapeutics, Inc." (CADL) at Buy with Decreased Target from $10 to $8 on, Dec 7th, 2022.

Judah has made no other calls on CADL in the last 4 months.



There is 1 other peer that has a rating on CADL. Out of the 1 peers that are also analyzing CADL, 0 agree with Judah's Rating of Hold.



This is the rating of the analyst that currently disagrees with Judah


  • Vernon Bernardino of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $11 on, Friday, December 2nd, 2022